By Michael A. Lesser, Esq. Posted on Sep 25, 2013 Dr. Frances Oldham Kelsey Released in Germany in 1957 as an all-purpose sedative, but later widely used as a preventative treatment for “morning sickness,”...
As a result of the widespread use of their deadly products, many of the manufacturers of asbestos-containing products have filed for Chapter 11 bankruptcy protection. After filing for bankruptcy, our laws protect asbestos companies from further individual lawsuits filed by people with mesothelioma or other asbestos-related disease. But before an asbestos company can reorganize and emerge from bankruptcy, courts require them to pay compensation for those injured by the company’s products and conduct. Part of the bankruptcy process, therefore, involves the company setting aside a specific amount of funds in order to pay the claims of all injured individuals. The sum of money set aside by the company, under court supervision, is referred to as a “bankruptcy trust.” Once the trust is established, it is the only way for victims injured by that company’s products to receive compensation from that company. The company can no longer be sued.
By David C. Strouss, Esq. Posted on Sep 23, 2013 Earlier this month, the FDA announced that it will require all extended-release and long-acting opioid analgesics intended to treat pain such as Percocet, Vicodin, Oxycontin, and others to have a new warning label....
By: Andrew S. Wainwright, Esq., Sep 19, 2013 3:47:00 PM A person who has been exposed to (breathed in) asbestos may be at risk for several diseases. It is not necessary to have worked directly with asbestos to have breathed it in. The primary health risks of asbestos...
Thornton Law Firm currently represents over 100 children with one of the most devastating types of birth defects, neural tube defects, arising from exposure to toxic chemicals and other hazardous substances. Neural tube defects are disorders of the central nervous system and involve such conditions as spina bifida (incomplete development of the spine), anencephaly (the skull does not close completely and part of the brain may be missing), and encephalocele (the brain is pushed through an opening in the skull).
When Ronald “Ron” Motley passed on August 22, 2013, not only did the legal world lose one of its brightest and most ferocious lights, those most in need of representation and justice lost one of their greatest champions.
The first DePuy ASR bellwether trial over Johnson & Johnson DePuy Unit’s hip implants, scheduled to begin today, September 9th in the consolidated federal Multi-District Litigation, has been adjourned for two weeks.
By Marilyn T. McGoldrick, Esq. Posted on Sep 3, 2013 The first bellwether trial in the federal court Multi-District Litigation over Johnson & Johnson's DePuy Unit's metal hip implants is scheduled to begin on Monday, September 9, 2013. The plaintiff is Ann...
C.R. Bard recently settled the second federal Avaulta transvaginal mesh bellwether case just before trial which was scheduled to start last week. The settlement terms between Bard and the plaintiff, a North Carolina woman named Wanda Queen, are undisclosed. The announcement was made by U.S. District Court Judge Joseph R. Goodwin, who presides over all six surgical mesh consolidated federal multi-district litigation (MDL) dockets. Besides the Bard consolidated cases, Judge Goodwin presides over litigation involving American Medical Systems, Inc., Boston Scientific Corp., Coloplast Corp., Cook Medical, Inc., and Ethicon, Inc.
DePuy Orthopaedics, Inc., recalled the DePuy ASR™ XL Acetabular Hip System on August 24, 2010, three years ago this coming Saturday. The three-year statute of limitations applicable to Massachusetts claims (and claims in states with a similar limitations period) could possibly expire in many cases at the end of this month. DePuy Orthopaedics, a division of Johnson & Johnson, recalled its ASR Hip System because of an exceptionally high failure rate and resulting metal poisoning. DePuy’s Pinnacle® metal-on-metal hip system, which remains on the market today but is being phased out by J&J, is experiencing similar failures.
On August 15, 2013, a West Virginia jury awarded Donna Cisson a $2 million verdict, $250,000 in compensatory damages and $1.75 million in punitive damages, against C. R. Bard for injuries caused by its transvaginal mesh implant Avaulta. Donna Cisson’s attorneys presented evidence that her vaginal mesh implant caused bleeding, constant intractable pain and bladder spasms. Ultimately Cisson endured several surgeries to remove much of the surgical mesh; she still has 22 inches of mesh inside her body and the constant pain.
Posted by Marilyn McGoldrick on Aug 16, 2013 12:02:00 PM The FDA issued a Drug Safety Communication yesterday about a popular class of antibiotics, including Bayer Pharmaceutical’s Cipro and Johnson & Johnson subsidiary Ortho-McNeil-Janssen Pharmaceutical’s...
